• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

    6/10/24 4:27:25 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Faulconbridge James A

    (Last) (First) (Middle)
    2381 ROSEGATE

    (Street)
    ROSEVILLE MN 55113

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HAWKINS INC [ HWKN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/06/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/06/2024 P 1,270 A $87.3994(1) 39,987 D
    Common Stock 06/06/2024 P 530 A $87.9536(2) 40,517 D
    Common Stock 06/07/2024 P 746 A $87.0114(3) 41,263 D
    Common Stock 06/07/2024 P 754 A $88.0416(4) 42,017 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects the weighted average price of 1,270 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 6, 2024 with purchase prices ranging from $86.88 to $87.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    2. Reflects the weighted average price of 530 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 6, 2024 with purchase prices ranging from $87.94 to $87.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    3. Reflects the weighted average price of 746 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 7, 2024 with purchase prices ranging from $86.50 to $87.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    4. Reflects the weighted average price of 754 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on June 7, 2024 with purchase prices ranging from $87.50 to $88.4276 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
    /s/ Joshua L. Colburn, Attorney-in-Fact 06/10/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HWKN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

      ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) -- – Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations

      6/11/25 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in the 2025 Wells Fargo Industrials Conference

      ROSEVILLE, Minn., May 20, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the Wells Fargo Industrials Conference on June 10, 2025. The conference will be held at the Loews Chicago from June 10 to June 12, 2025. The conference will consist of fireside chats and one-on-one meetings with senior executives from leading companies in a variety of industries. Hawkins management will participate on June 10, 2025. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinator or Hawkins Investor Relations at ir@hawkinsinc

      5/20/25 5:04:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary